Related Experiment Video
Updated: Apr 22, 2026

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
Practical implications of the migraine cardio- and cerebrovascular association: unmet needs of patients
Hans-Christoph Diener1, Tobias Kurth2, Dagny Holle3
1Department of Neurology and Headache Center, University Hospital Essen, Germany hans.diener@uni-duisburg-essen.de.
Insights
Migraine patients with cardiovascular disease require careful medication choices, as some common migraine drugs are contraindicated. This highlights an unmet need for safe and effective treatments in this comorbid population.
Area of Science:
- Neurology
- Cardiology
- Pharmacology
Background:
- Migraine is increasingly linked to cardiovascular disease and stroke.
- Comorbid migraine and cardiovascular/cerebrovascular disease presents therapeutic challenges.
Purpose of the Study:
- To review medical therapy modifications for patients with comorbid migraine and cardio-cerebrovascular disorders.
- To identify contraindications for migraine treatments in these patients.
Main Methods:
- Literature review of publications from the last 15 years.
- Analysis of medical therapy modifications in patients with comorbid conditions.
Main Results:
- Ergots and triptans are contraindicated for migraine attacks in some patients.
- Aspirin and NSAIDs are contraindicated in patients with cerebral bleeding.
- Certain acute migraine treatments are contraindicated in patients with coronary heart disease.
Conclusions:
- There is a significant unmet need for safe and effective migraine treatments in patients with cardiovascular and cerebrovascular disease.
- Therapeutic strategies must consider the contraindications of various migraine medications.
Background:
Numerous studies have described a relationship between migraine and stroke, and there is emerging evidence that migraine is also associated with cardiovascular disease. The combination of migraine and both cerebrovascular and cardiovascular disease has implications for therapy.
Methods:
We conducted a review of the modifications in medical therapy in patients with comorbid migraine and cardio- and cerebrovascular disorders based on publications from the last 15 years.
Results:
Some drugs are contraindicated to treat migraine attacks (ergots, triptans) or for migraine prevention in patients after transient ischemic attack (TIA)/ischemic stroke. Aspirin and nonsteroidal anti-inflammatory drugs (NSAIDs) are contraindicated in patients with cerebral bleeding. Some drugs for the treatment of acute migraine attacks are contraindicated in patients with symptomatic coronary heart disease.
Conclusions:
Given the large number of patients with comorbid migraine and cardiovascular as well as cerebrovascular disease, there is an unmet need to treat these patients.
Related Concept Videos
Arteries of the Head and Neck
The internal carotid arteries supply blood to the anterior portion of the cerebrum. They enter the...
Mitral Valve Prolapse III: Nursing Management
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Cardiovascular Drugs: Classification based on Therapeutic Indications
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...

